Bibliotecas PUC-SP - Busca Integrada

Autoimmune Disease Genetics 2013

Por Timothy B. Niewold, George N. Goulielmos, Shervin Assassi
Publicado no Journal of Immunology Research (2014-01-01)

Addressing statistical challenges in the analysis of proteomics data with extremely small sample size: a simulation study

Por Kyung Hyun Lee, Shervin Assassi, Chandra Mohan, Claudia Pedroza
Publicado no BMC Genomics (2024-11-01)

Autoimmune Disease Genetics

Por Timothy B. Niewold, George N. Goulielmos, Mohammed Tikly, Shervin Assassi
Publicado no Clinical and Developmental Immunology (2012-01-01)

Enrichment Strategy for Systemic Sclerosis Clinical Trials Targeting Skin Fibrosis: A Prospective, Multiethnic Cohort Study

Por Carina Mihai, Rucsandra Dobrota, Shervin Assassi, Maureen D. Mayes, Oliver Distler
Publicado no ACR Open Rheumatology (2020-08-01)

Lack of association of the PLD4 SNP rs2841277 with systemic sclerosis in a European American population

Por Yunqing Ma, Maureen D. Mayes, Xinjian Guo, Shervin Assassi, Xiaodong Zhou
Publicado no Scientific Reports (2024-12-01)

Transcriptional insights into pathogenesis of cutaneous systemic sclerosis using pathway driven meta-analysis assisted by machine learning methods.

Por Xiao Xu, Meera Ramanujam, Sudha Visvanathan, Shervin Assassi, Zheng Liu, Li Li
Publicado no PLoS ONE (2020-01-01)

Proteomic aptamer analysis reveals serum markers that characterize preclinical systemic sclerosis (SSc) patients at risk for progression toward definite SSc

Por Chiara Bellocchi, Shervin Assassi, Marka Lyons, Maurizio Marchini, Chandra Mohan, Alessandro Santaniello, Lorenzo Beretta
Publicado no Arthritis Research & Therapy (2023-01-01)

Quantitative proteomic screening uncovers candidate diagnostic and monitoring serum biomarkers of ankylosing spondylitis

Por Mark Hwang, Shervin Assassi, Jim Zheng, Jessica Castillo, Reyna Chavez, Kamala Vanarsa, Chandra Mohan, John Reveille
Publicado no Arthritis Research & Therapy (2023-04-01)

Multiomic study of skin, peripheral blood, and serum: is serum proteome a reflection of disease process at the end-organ level in systemic sclerosis?

Por Victor Farutin, Elma Kurtagic, Joël R. Pradines, Ishan Capila, Maureen D. Mayes, Minghua Wu, Anthony M. Manning, Shervin Assassi
Publicado no Arthritis Research & Therapy (2021-10-01)

Deep Learning Classification of Systemic Sclerosis Skin Using the MobileNetV2 Model

Por Metin Akay, Yong Du, Cheryl L. Sershen, Minghua Wu, Ting Y. Chen, Shervin Assassi, Chandra Mohan, Yasemin M. Akay
Publicado no IEEE Open Journal of Engineering in Medicine and Biology (2021-01-01)

Combining Clinical and Biological Data to Predict Progressive Pulmonary Fibrosis in Patients With Systemic Sclerosis Despite Immunomodulatory Therapy

Por Elizabeth R. Volkmann, Holly Wilhalme, Shervin Assassi, Grace Hyun J. Kim, Jonathan Goldin, Masataka Kuwana, Donald P. Tashkin, Michael D. Roth
Publicado no ACR Open Rheumatology (2023-10-01)

Reactome pathway analysis from whole-blood transcriptome reveals unique characteristics of systemic sclerosis patients at the preclinical stage

Por Chiara Bellocchi, Chiara Bellocchi, Xuan Wang, Marka A. Lyons, Maurizio Marchini, Maurizio Lorini, Vincenzo Carbonelli, Nicola Montano, Shervin Assassi, Lorenzo Beretta
Publicado no Frontiers in Immunology (2023-11-01)

Right bundle branch block: a predictor of mortality in early systemic sclerosis.

Por Hilda T Draeger, Shervin Assassi, Roozbeh Sharif, Emilio B Gonzalez, Brock E Harper, Frank C Arnett, Ameena Manzoor, Richard A Lange, Maureen D Mayes
Publicado no PLoS ONE (2013-01-01)

Correction: Right Bundle Branch Block: A Predictor of Mortality in Early Systemic Sclerosis.

Por Hilda T. Draeger, Shervin Assassi, Roozbeh Sharif, Emilio B. Gonzalez, Brock E. Harper, Frank C. Arnett, Ameena Manzoor, Richard A. Lange, Maureen D. Mayes
Publicado no PLoS ONE (2014-01-01)

Effect of Nintedanib on Progression of Systemic Sclerosis‐Associated Interstitial Lung Disease Over 100 Weeks: Data From a Randomized Controlled Trial

Por Shervin Assassi, Oliver Distler, Yannick Allanore, Takashi Ogura, John Varga, Serena Vettori, Bruno Crestani, Florian Voss, Margarida Alves, Susanne Stowasser, Toby M. Maher, SENSCIS trial investigators
Publicado no ACR Open Rheumatology (2022-10-01)

The Effect of Anti‐Scl‐70 Antibody Determination Method on Its Predictive Significance for Interstitial Lung Disease Progression in Systemic Sclerosis

Por Bochra Jandali, Gloria A. Salazar, Marie Hudson, Marvin J. Fritzler, Marka A. Lyons, Rosa M. Estrada‐Y‐Martin, Julio Charles, Katherine A. Terracina, Maureen D. Mayes, Shervin Assassi
Publicado no ACR Open Rheumatology (2022-04-01)

Predictors of fatigue severity in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort.

Por Shervin Assassi, Astrud L Leyva, Maureen D Mayes, Roozbeh Sharif, Deepthi K Nair, Michael Fischbach, Ngan Nguyen, John D Reveille, Emilio B Gonzalez, Terry A McNearney, GENISOS Study Group
Publicado no PLoS ONE (2011-01-01)

ALK5 inhibitor impact on bleomycin-induced systemic sclerosis mouse model via multifunctional optical coherence tomography

Por Pavel V. Nikitin, Harshdeep S. Chawla, Jessica Gutierrez, Geethangili Madamanchi, Manmohan Singh, Salavat R. Aglyamov, Minghua Wu, Jerry Alonso, Matthew Fronheiser, Juliana Coculo, Shuyan Du, Shervin Assassi, Kirill V. Larin
Publicado no APL Bioengineering (2025-11-01)

Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression

Por Toby M Maher, Michael Kreuter, Vanessa Smith, Yannick Allanore, Elizabeth R Volkmann, Dinesh Khanna, Christopher P Denton, Anna-Maria Hoffmann-Vold, Shervin Assassi, Masataka Kuwana, Margarida Alves, Christian Stock, Steven Sambevski
Publicado no RMD Open (2023-02-01)

OTUD6B-AS1 Might Be a Novel Regulator of Apoptosis in Systemic Sclerosis

Por Miki Takata, Elena Pachera, Mojca Frank-Bertoncelj, Anastasiia Kozlova, Astrid Jüngel, Michael L. Whitfield, Shervin Assassi, Maurizio Calcagni, Jeska de Vries-Bouwstra, Tom W. Huizinga, Fina Kurreeman, Gabriela Kania, Oliver Distler
Publicado no Frontiers in Immunology (2019-05-01)